Delivery Order SPE2DX22D0010-SPE2D825FGP65
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta 54mg tablets (100-count units) valued at $12,350.28 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Concerta ER Tablets 18mg, with a ceiling value of $1,588.38. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Concerta ER (extended-release) 27 mg tablets. This competitively awarded, firm fixed-price delivery order has a ceiling value of approximately $24.9K and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a delivery order, this contract is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,675.27 to AmerisourceBergen Drug Corp for the supply of Concerta HCL 18mg tablets (100 count) on July 31, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,101.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Concerta ER (extended-release) tablets at 18mg strength. This non-competitive delivery order, issued on December 3, 2025, with completion targeted for December 4, 2025, represents a small-value pharmaceutical procurement for military healthcare needs. The award was made to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $24.8K to supply Concerta ER tablets 36mg. The contract, issued on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $27,314.50 for 100 tablets of Concerta ER 54 mg on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $3,836.73 and an ultimate completion date of July 15, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a $45,744.59 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger indefinite delivery contract vehicle. Performance will be executed from...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FGP65Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,139.22 to AmerisourceBergen Drug Corp for 27mg Concerta ER tablets on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with the Defense Logistics Agency. The pharmaceutical products will be delivered to the vendor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical supplier for federal medical procurement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor supporting military and veteran healthcare systems through an extensive portfolio of federal contracts. The company holds a significant $999,999,999 indefinite delivery contract with DLA Troop Support Medical through December 2026, which authorizes supply of pharmaceuticals and medical commodities to defense healthcare programs globally. This delivery order for Concerta ER tablets—a controlled-release methylphenidate formulation used for attention deficit disorders—exemplifies the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and other federal healthcare systems through competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.1k | 6/26/25 |